GAVRETO

Indicated For

RET fusion-positive non-small cell lung cancer, RET fusion-positive thyroid cancer

About This Medication

# RIGEL ONECARE Guide: Getting GAVRETO at Low Cost ## What is GAVRETO? GAVRETO (pralsetinib) is a prescription medication used to treat two types of cancer: - RET fusion-positive non-small cell lung cancer - RET fusion-positive thyroid cancer This guide explains how to get GAVRETO through RIGEL ONECARE, Rigel Pharmaceuticals' patient assistance program that helps reduce your medication costs. ## Who Can Apply? You may qualify for RIGEL ONECARE if you: - Have a valid prescription for GAVRETO from your doctor - Are a U.S. resident - Meet the program's income requirements - Are uninsured, underinsured, or have commercial insurance ### Income Requirements Income limits vary based on your household size and change annually. Contact the program directly at (833) 744-3562 to learn the current limits, or visit www.RIGELONECARE.com. Generally, the program serves patients with moderate to lower incomes, though specific thresholds depend on your circumstances. ### Insurance Status **Uninsured or Underinsured Patients:** You may receive GAVRETO at no cost or at a reduced price. **Commercial Insurance Patients:** The program offers copay assistance, helping you pay a lower copay amount while your insurance covers the remainder of the drug cost. **Medicare/Medicaid Patients:** Contact the program directly to discuss your specific coverage situation, as eligibility may vary. ## What You'll Need to Apply Have these documents ready before you apply: 1. **Proof of Income** – Recent tax return, pay stub, or benefit statement from the last 30-60 days 2. **Proof of Residency** – Utility bill, lease agreement, or government-issued ID with your current address 3. **Valid Prescription** – A prescription from your doctor for GAVRETO 4. **Insurance Information** – Insurance card (if applicable) or proof of uninsured status ## How to Apply: 4 Easy Steps **Step 1: Start Your Application** Visit www.RIGELONECARE.com or call (833) 744-3562. A patient specialist will help you determine eligibility and begin the process. **Step 2: Submit Your Documents** Provide the required documents listed above. You can submit these online, by mail, or by phone—choose whichever is easiest for you. **Step 3: Wait for Approval** The program typically reviews applications within 1-2 weeks. You'll be notified by phone, email, or mail about your approval status. **Step 4: Get Your Medication** Once approved, your prescription will be filled through the program. Your pharmacy will handle the paperwork, and you'll pick up your medication as directed by your doctor. ## Timeline and Reauthorization Your assistance is approved for **one year**. You'll need to reapply annually to continue receiving program benefits. The program will notify you before your authorization expires, giving you time to submit new documents. ## Savings Card Option RIGEL ONECARE also offers a **savings card** for eligible patients. This card may provide additional discounts at the pharmacy, even if you don't qualify for full program assistance. Ask your doctor or pharmacist if a savings card is right for your situation. ## What If You're Denied? If your application is denied, don't lose hope. Contact the program immediately at (833) 744-3562 to: - Understand why you were denied - Learn about alternative assistance options - Appeal the decision if you believe there was an error - Explore other patient resources ## Additional Resources - **Website:** www.RIGELONECARE.com - **Phone:** (833) 744-3562 - **Hours:** Available to answer questions about eligibility and applications The patient specialists at RIGEL ONECARE speak multiple languages and can answer questions about your specific situation. Don't hesitate to call—they're there to help. ## Getting Started Today If you've been prescribed GAVRETO and are concerned about cost, reaching out to RIGEL ONECARE is your first step toward affordable access. Work with your doctor's office—many can help submit your application—and contact the program today at (833) 744-3562 or online at www.RIGELONECARE.com.

Program information last verified: March 25, 2026